Junctional Epidermolysis Bullosa Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Junctional Epidermolysis Bullosa.
Found 1 Approved Drug for Junctional Epidermolysis Bullosa
Filsuvez
Generic Name
Triterpenes
Filsuvez
Generic Name
Triterpenes
Form: Gel
Method of administration: Topical
FDA approval date: February 14, 2024
FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older. FILSUVEZ topical gel is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa in adult and pediatric patients 6 months of age and older. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances